Tenascin-C deficiency attenuates TGF-β-mediated fibrosis following murine lung injury

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 299, Issue 6, 2010, Pages

  Carey, William A ^a,b   Taylor, Glen D ^a   Dean, Willow B ^a   Bristow, James D ^a,b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c LAWRENCE BERKELEY NATIONAL LABORATORY   (United States)

Author keywords

Acute lung injury; Myofibroblast; Pulmonary fibrosis; Transforming growth factor signaling

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; BLEOMYCIN; COLLAGEN; COLLAGEN TYPE 1; PROTEASOME; SMAD2 PROTEIN; SMAD3 PROTEIN; TENASCIN; TRANSFORMING GROWTH FACTOR BETA; UBIQUITIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; EXTRACELLULAR MATRIX; IN VITRO STUDY; LUNG FIBROSIS; LUNG INJURY; LUNG INTERSTITIUM; MOUSE; MYOFIBROBLAST; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; STAINING; WILD TYPE;

ANIMALS; CELL LINE; COLLAGEN; FIBROBLASTS; FIBROSIS; HUMANS; LUNG; LUNG INJURY; MICE; MICE, KNOCKOUT; SIGNAL TRANSDUCTION; SMAD3 PROTEIN; TENASCIN; TRANSFORMING GROWTH FACTOR BETA;

EID: 78649893128     PISSN: 10400605     EISSN: 15221504     Source Type: Journal    
DOI: 10.1152/ajplung.00385.2009     Document Type: Article

References (58)

1. Amin K, Ludviksdotti D, Janson C, Nettelbladt O, Bjornsson E, Roomans GM, Boman G, Seveus L, Venge P. Inflammation and structural changes in the airways of patients with atopic and nonatopic asthma. Am J Respir Crit Care Med 162: 2295-2301, 2000. (Pubitemid 32051703)
2. Bland RD, Mokres LM, Ertsey R, Jacobson BE, Jiang S, Rabinovitch M, Xu L, Shinwell ES, Zhang F, Beasley MA. Mechanical ventilation with 40% oxygen reduces pulmonary expression of genes that regulate lung development and impairs alveolar septation in newborn mice. Am J Physiol Lung Cell Mol Physiol 293: L1099-L1110, 2007.
3. Burch GH, Gong Y, Liu W, Dettman RW, Curry CJ, Smith L, Miller WL, Bristow J. Tenascin-X deficiency is associated with the Ehlers-Danlos syndrome. Nat Genet 17: 104-108, 1997.
4. Chapman HA. Disorders of lung matrix remodeling. J Clin Invest 113: 148-157, 2004.
5. Chiquet-Ehrismann R, Chiquet M. Tenascins: regulation and putative functions during pathological stress. J Pathol 200: 488-499, 2003.
6. Cifuentes-Diaz C, Faille L, Goudou D, Schachner M, Rieger F, Angaut-Petit D. Abnormal reinnervation of skeletal muscle in a tenascin-C-deficient mouse. J Neurosci Res 67: 93-99, 2002.
7. Crystal RG, Bitterman PB, Mossman B, Schwarz MI, Sheppard D, Almasy L, Chapman HA, Friedman SL, King TE, Leiwand LA, Liotta L, Martin GR, Schwartz DA, Schultz GS, Wagner CR, Musson RA. Future research directions in idiopathic pulmonary fibrosis: summary of a National Heart, Lung, and Blood Institute working group. Am J Respir Crit Care Med 166: 236-246, 2002.
8. Datto M, Wang XF. Ubiquitin-mediated degradation a mechanism for fine-tuning TGF-beta signaling. Cell 121: 2-4, 2005. (Pubitemid 40501160)
9. Evans RA, Tian YC, Steadman R, Phillips AO. TGF-β1-mediated fibroblast-myofibroblast terminal differentiation - the role of smad proteins. Exp Cell Res 282: 90-100, 2003.
10. Fineschi S, Bongiovanni M, Donati Y, Djaafar S, Naso F, Goffin L, Argiroffo CB, Pache JC, Dayer JM, Ferrari-Lacraz S, Chizzolini C. In vivo investigations on anti-fibrotic potential of proteasome inhibition in lung and skin fibrosis. Am J Respir Cell Mol Biol 39: 458-465, 2008.
11. Forsberg E, Hirsch E, Fröhlich L, Meyer M, Ekblom P, Aszodi A, Werner S, Fässler R. Skin wounds and severed nerves heal normally in mice lacking tenascin-c. Proc Natl Acad Sci USA 93: 6594-6599, 1996.
12. Frank J, Roux J, Kawakatsu H, Su G, Dagenais A, Berthiaume Y, Howard M, Canessa CM, Fang X, Sheppard D, Matthay MA, Pittet JF. Transforming growth factor beta-1 decreases expression of the epithelial sodium channel alphaENaC and alveolar epithelial vectorial sodium and fluid transport via an ERK1/2-dependent mechanism. J Biol Chem 278: 43939-43950, 2003.
13. Fukasawa H, Yamamoto T, Suzuki H, Togawa A, Ohashi N, Fujigaki Y, Uchida C, Aoki M, Hosono M, Kitagawa M, Hishida A. Treatment with anti-TGF-beta antibody ameliorates chronic progressive nephritis by inhibiting Smad/TGF-beta signaling. Kidney Int 65: 63-74, 2004.
14. Gharaee-Kermani M, McCullumsmith RE, Charo IF, Kunkel SL, Phan SH. CC-chemokine receptor 2 required for bleomycin-induced pulmonary fibrosis. Cytokine 24: 266-276, 2003.
15. Hall SM, Hislop AA, Pierce CM, Haworth SG. Prenatal origins of human intrapulmonary arteries: formation and smooth muscle maturation. Am J Respir Cell Mol Biol 23: 194-203, 2000.
16. Ignotz RA, Heino J, Massagué J. Regulation of cell adhesion receptors by transforming growth factor-β. J Biol Chem 264: 389-392, 1989.
17. Irintchev A, Rollenhagen A, Troncoso E, Kiss JZ, Schachner M. Structural and functional aberrations in the cerebral cortex of tenascin-C deficient mice. Cereb Cortex 15: 950-962, 2004.
18. Jones FS, Jones PL. The tenascin family of ECM glycoproteins: structure, function, and regulation during embryonic development and tissue remodeling. Dev Dyn 218: 235-259, 2000.
19. Kaarteenaho-Wiik R, Kinnula V, Herva R, Pääkkö P, Pöllänen R, Soini Y. Distribution and mRNA expression of tenascin-c developing human lung. Am J Respir Cell Mol Biol 25: 341-346, 2001.
20. Kaminski N, Allard JD, Pittet JF, Zuo F, Griffiths MJD, Morri D, Huang X, Sheppard D, Heller RA. Global analysis of gene expression in pulmonary fibrosis reveals distinct programs regulating lung inflammation and fibrosis. Proc Natl Acad Sci USA 97: 1778-1783, 2000.
21. Kolb M, Margetts PJ, Anthony DC, Pitossi F, Gauldie J. Transient expression of IL-1β induces acute lung injury and chronic repair leading to pulmonary fibrosis. J Clin Invest 107: 1529-1536, 2001.
22. Kubista M, Andrade JM, Bengtsson M, Forootan A, Jonák J, Lind K, Sindelka R, Sjöback R, Sjögreen B, Strömbom L, Ståhlberg A, Zoric N. The real-time polymerase chain reaction. Mol Aspects Med 27: 95-125, 2006.
23. Kuwahara F, Kai H, Tokuda K, Takeya M, Takeshita A, Egashira K, Imaizumi T. Transforming growth factor-beta function blocking prevents myocardial fibrosis and diastolic dysfunction in pressure-overloaded rats. Circulation 106: 130-135, 2002.
24. Laitinen A, Altraja A, Kampe M, Linden M, Virtanen I, Laitinen LA. Tenascin is increased in airway basement membrane of asthmatics and decreased by an inhaled steroid. Am J Respir Crit Care Med 156: 951-958, 1997.
25. Liao YF, Gotwals PJ, Koteliansky VE, Sheppard D. The EIIIA segment of fibronectin is a ligand for integrins α9β1 and α4β1 providing a novel mechanism for regulating cell adhesion by alternate splicing. J Biol Chem 277: 14467-14474, 2002.
26. Liao YF, Wieder KG, Classen JM, Van De Water L. Identification of two amino acids within the EIIIA (ED-A) segment of fibronectin constituting the epitope for two function-blocking monoclonal antibodies. J Biol Chem 274: 17876-17884, 1999.
27. Liu JY, Sime PJ, Wu T, Warshamana GS, Pociask D, Tsai SY, Brody AR. Transforming growth factor-β1 overexpression in tumor necrosis factor-α receptor knockout mice induces fibroproliferative lung disease. Am J Respir Cell Mol Biol 25: 3-7, 2001.
28. McMillan SJ, Xanthou G, Lloyd CM. Manipulation of allergen-induced airway remodeling by treatment with anti-TGF-beta antibody: effect on the Smad signaling pathway. J Immunol 174: 5774-5780, 2005.
29. Morellini F, Schachner M. Enhanced novelty-induced activity, reduced anxiety, delayed resynchronizations to daylight reversal and weaker muscle strength in tenascin-C-deficient mice. Eur J Neurosci 23: 1255-1268, 2006.
30. Munger JS, Huang X, Kawakatsu H, Griffiths MJ, Dalton SL, Wu J, Pittet JF, Kaminski N, Garat C, Matthay MA, Rifkin DB, Sheppard D. The integrin αvβ6 binds and activates latent TGFβ1: a mechanism for regulating pulmonary inflammation and fibrosis. Cell 96: 319-328, 1999.
31. Nakao N, Hiraiwa N, Yoshiki A, Ike F, Kusakabe M. Tenascin-C promotes healing of Habu-snake venom-induced glomerulonephritis: studies in knockout congenic mice and in culture. Am J Pathol 152: 1237-1245, 1998.
32. Nakao A, Imamura T, Souchelnytskyi S, Kawabata M, Ishisaki A, Oeda E, Tamaki K, Hanai JI, Heldin CH, Miyazono K, ten Dijke P. TGF-β receptor-mediated signaling through Smad2, Smad3 and Smad4. EMBO J 16: 5353-5362, 1997.
33. Pääkkö P, Kaarteenaho-Wiik R, Pöllänen R, Soini Y. Tenascin mRNA expression at the foci of recent injury in usual interstitial pneumonia. Am J Respir Crit Care Med 161: 967-972, 2000. (Pubitemid 30171759)
34. Pechkovsky DV, Scaffidi AK, Hackett TL, Ballard J, Shaheen F, Thompson PJ, Thannickal VJ, Knight DA. Transforming growth factor beta1 induces alphav-beta3 integrin expression in human lung fibroblasts via a beta3 integrin-, c-Src-, and p38 MAPK-dependent pathway. J Biol Chem 283: 12898-12908, 2008.
35. Phan SH. The myofibroblast in pulmonary fibrosis. Chest 122: 286S-289S, 2002.
36. Pittet JF, Griffiths MJD, Geiser T, Kaminski N, Dalton SL, Huang X, Brown LAS, Gotwals PJ, Koteliansky VE, Matthay MA, Rifkin DB, Sheppard D. TGF-β is a critical mediator of acute lung injury. J Clin Invest 107: 1537-1544, 2001.
37. Powell DW, Mifflin RC, Valentich JD, Crowe SE, Saada JI, West AB. Myofibroblasts. I. Paracrine cells important in health and disease. Am J Physiol Cell Physiol 277: C1-C19, 1999.
38. Prieto AL, Edelman GM, Crossin KL. Multiple integrins mediate cell attachment to cytotactin/tenascin. Proc Natl Acad Sci USA 90: 10154-10158, 1993.
39. Ramos C, Becerril C, Montaño M, García-De-Alba C, Ramirez R, Checa M, Pardo A, Selman M. FGF-1 reverts epithelial-mesenchymal transition induced by TGF-β1 through MAPK/ERK kiinase pathway. Am J Physiol Lung Cell Mol Physiol 299: L222-L231, 2010.
40. Roth-Kleiner M, Hirsch E, Schittny JC. Fetal lungs of tenascinc- deficient mice grow well, but branch poorly in organ culture. Am J Respir Cell Mol Biol 30: 360-366, 2004.
41. Saga Y, Yagi T, Ikawa Y, Sakakura T, Aizawa S. Mice develop normally without tenascin. Genes Dev 6: 1821-1831, 1992.
42. Scaffidi AK, Moodley YP, Weichselbaum M, Thompson PJ, Knight DA. Regulation of human lung fibroblast phenotype and function by vitronectin and vitronectin integrins. J Cell Sci 114: 3507-3516, 2001.
43. Scaffidi AK, Petrovic N, Moodley YP, Fogel-Petrovic M, Kroeger KM, Seeber RM, Eidne KA, Thompson PJ, Knight DA. αvβ3 integrin interacts with the TGFβ type II receptor to potentiate the proliferative effects of TGFβ1 in living human lung fibroblasts. J Biol Chem 279: 37726-37733, 2004.
44. Serini G, Bochaton-Piallat ML, Ropraz P, Geinoz A, Borsi L, Zardi L, Gabbiani G. The fibronectin domain ED-A is crucial for myofibroblastic phenotype induction by transforming growth factor-β1. J Cell Biol 142: 873-881, 1998.
45. Shimabukuro DW, Sawa T, Gropper MA. Injury and repair in lung and airways. Crit Care Med 31: S524-S531, 2003.
46. Snyder JC, Zemke AC, Stripp BR. Reparative capacity of airway epithelium impacts deposition and remodeling of extracellular matrix. Am J Respir Cell Mol Biol 40: 633-642, 2009.
47. Thannickal VJ, Lee DY, White ES, Cui Z, Larios JM, Chacon R, Horowitz JC, Day RM, Thomas PE. Myofibroblast differentiation by transforming growth factor-β1 is dependent on cell adhesion and integrin signaling via focal adhesion kinase. J Biol Chem 278: 12384-12398, 2003.
48. Weiss CH, Budinger GR, Mutlu GM, Jain M. Proteasomal regulation of pulmonary fibrosis. Proc Am Thorac Soc 7: 77-83, 2010.
49. Williams SA, Schwarzbauer JE. A shared mechanism of adhesion modulation for tenascin-C and fibulin-1. Mol Biol Cell 20: 1141-1149, 2009.
50. Xhang HY, Phan SH. Inhibition of myofibroblast apoptosis by transforming growth factor β1. Am J Respir Cell Mol Biol 21: 658-665, 1999.
51. Xin H, Xu X, Li L, Ning H, Rong Y, Shang Y, Wang Y, Fu XY, Chang Z. CHIP controls the sensitivity of transforming growth factor-beta signaling by modulating the basal level of Smad3 through ubiquitin-mediated degradation. J Biol Chem 280: 20842-20850, 2005. (Pubitemid 40776789)
52. Yokosaki Y, Monis H, Chen J, Sheppard D. Differential effects of the integrins α9β1, αvβ3, and αvβ6 on cell proliferative responses to tenascin: roles of the β subunit extracellular and cytoplasmic domains. J Biol Chem 271: 24144-24150, 1996.
53. Yokoyama K, Erickson HP, Ikeda Y, Takada Y. Identification of amino acid sequences in fibrinogen γ-chain and tenascin-c C-terminal domains critical for binding to integrin αvβ3. J Biol Chem 275: 16891-16898, 2000.
54. Young SL, Chang LY, Erickson HP. Tenascin-c in rat lung: distribution, ontogeny and role in branching morphogenesis. Dev Biol 161: 615-625, 1994.
55. Zhang K, Gharaee-Kermani M, McGarry B, Remick D, Phan SH. TNF-α-mediated lung cytokine networking and eosinophil recruitment in pulmonary fibrosis. J Immunol 158: 954-959, 1997.
56. Zhao J, Shi W, Wang YL, Chen Bingas PH, Datto MB, Frederick JP, Wang XF, Warburton D. Smad3 deficiency attenuates bleomycin-induced pulmonary fibrosis in mice. Am J Physiol Lung Cell Mol Physiol 282: L585-L593, 2002.
57. Zhao Y, Young SL, McIntosh JC. Induction of tenascin in rat lungs undergoing bleomycin-induced pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol 274: L1049-L1057, 1998.
58. Zuo F, Kaminski N, Eugui E, Allard J, Yakhini Z, Ben-Dor A, Lollini L, Morris D, Kim Y, DeLustro B, Sheppard D, Pardo A, Selman M, Heller RA. Gene expression analysis reveals matrilysin as a key regulator of pulmonary fibrosis in mice and humans. Proc Natl Acad Sci USA 99: 6292-6297, 2002.